Urethane, formerly marketed as an inactive ingredient in Profenil injection, was determined to be carcinogenic and was removed from the Canadian, US, and UK markets in 1963.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Urethane may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Urethane. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Urethane. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Urethane. |
| Hydrocodone | Urethane may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Urethane. |
| Magnesium sulfate | The therapeutic efficacy of Urethane can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Urethane may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Urethane may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Urethane. |
| Mirtazapine | Urethane may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Urethane. |
| Orphenadrine | Urethane may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Urethane may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Urethane. |
| Pramipexole | Urethane may increase the sedative activities of Pramipexole. |
| Ropinirole | Urethane may increase the sedative activities of Ropinirole. |
| Rotigotine | Urethane may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Urethane. |
| Sodium oxybate | Urethane may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Urethane may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Urethane. |
| Thalidomide | Urethane may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Urethane may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Urethane. |
| Ethanol | Urethane may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Urethane may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Urethane. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Urethane is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Urethane is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Urethane is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Urethane is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Urethane is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Urethane is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Urethane is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Urethane is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Urethane is combined with Escitalopram. |
| Zimelidine | The risk or severity of adverse effects can be increased when Urethane is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Urethane is combined with Dapoxetine. |
| Milnacipran | The risk or severity of adverse effects can be increased when Urethane is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Urethane is combined with Desvenlafaxine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Urethane is combined with Seproxetine. |
| Indalpine | The risk or severity of adverse effects can be increased when Urethane is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Urethane is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Urethane is combined with Alaproclate. |
| Amitriptyline | The risk or severity of CNS depression can be increased when Amitriptyline is combined with Urethane. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Urethane. |
| Imipramine | The risk or severity of CNS depression can be increased when Imipramine is combined with Urethane. |
| Nortriptyline | The risk or severity of CNS depression can be increased when Nortriptyline is combined with Urethane. |
| Amoxapine | The risk or severity of CNS depression can be increased when Amoxapine is combined with Urethane. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Urethane. |
| Cocaine | The risk or severity of methemoglobinemia can be increased when Urethane is combined with Cocaine. |
| Maprotiline | The risk or severity of CNS depression can be increased when Maprotiline is combined with Urethane. |
| Doxepin | The risk or severity of CNS depression can be increased when Doxepin is combined with Urethane. |
| Desipramine | The risk or severity of CNS depression can be increased when Desipramine is combined with Urethane. |
| Pizotifen | The risk or severity of CNS depression can be increased when Urethane is combined with Pizotifen. |
| Dosulepin | The risk or severity of CNS depression can be increased when Urethane is combined with Dosulepin. |
| Zopiclone | The risk or severity of adverse effects can be increased when Urethane is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Urethane. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Urethane. |
| Tryptophan | The risk or severity of CNS depression can be increased when Tryptophan is combined with Urethane. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Urethane. |
| Lorazepam | The risk or severity of CNS depression can be increased when Lorazepam is combined with Urethane. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Urethane. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Urethane. |
| Reserpine | The risk or severity of CNS depression can be increased when Reserpine is combined with Urethane. |
| Eletriptan | The risk or severity of CNS depression can be increased when Eletriptan is combined with Urethane. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Urethane. |
| Temazepam | The risk or severity of CNS depression can be increased when Temazepam is combined with Urethane. |
| Reboxetine | The risk or severity of CNS depression can be increased when Reboxetine is combined with Urethane. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Urethane. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Urethane. |
| Methysergide | The risk or severity of CNS depression can be increased when Methysergide is combined with Urethane. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Urethane. |
| Phenytoin | The risk or severity of CNS depression can be increased when Phenytoin is combined with Urethane. |
| Topiramate | The risk or severity of CNS depression can be increased when Topiramate is combined with Urethane. |
| Clemastine | The risk or severity of CNS depression can be increased when Clemastine is combined with Urethane. |
| Venlafaxine | The risk or severity of CNS depression can be increased when Venlafaxine is combined with Urethane. |
| Etomidate | The risk or severity of CNS depression can be increased when Etomidate is combined with Urethane. |
| Morphine | The risk or severity of CNS depression can be increased when Morphine is combined with Urethane. |
| Talbutal | The risk or severity of CNS depression can be increased when Talbutal is combined with Urethane. |
| Pentobarbital | The risk or severity of CNS depression can be increased when Pentobarbital is combined with Urethane. |
| Valproic acid | The risk or severity of CNS depression can be increased when Valproic acid is combined with Urethane. |
| Zolmitriptan | The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Urethane. |
| Codeine | The risk or severity of CNS depression can be increased when Codeine is combined with Urethane. |
| Dihydroergotamine | The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Urethane. |
| Tolcapone | The risk or severity of CNS depression can be increased when Tolcapone is combined with Urethane. |
| Hydromorphone | The risk or severity of CNS depression can be increased when Hydromorphone is combined with Urethane. |
| Olanzapine | The risk or severity of CNS depression can be increased when Olanzapine is combined with Urethane. |
| Cetirizine | The risk or severity of CNS depression can be increased when Cetirizine is combined with Urethane. |
| Protriptyline | The risk or severity of CNS depression can be increased when Protriptyline is combined with Urethane. |
| Trimethadione | The risk or severity of CNS depression can be increased when Trimethadione is combined with Urethane. |
| Clobazam | The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Urethane. |
| Chlorzoxazone | The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Urethane. |
| Clozapine | The risk or severity of CNS depression can be increased when Clozapine is combined with Urethane. |
| Meprobamate | The risk or severity of CNS depression can be increased when Meprobamate is combined with Urethane. |
| Thiethylperazine | The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Urethane. |
| Palonosetron | The risk or severity of CNS depression can be increased when Palonosetron is combined with Urethane. |
| Sulpiride | The risk or severity of CNS depression can be increased when Sulpiride is combined with Urethane. |
| Alprazolam | The risk or severity of CNS depression can be increased when Alprazolam is combined with Urethane. |